Natural History in Fabry Renal Disease

Request Access

Progressive podocyte injury and globotriaosylceramide (GL-3) accumulation in young patients with Fabry disease.

Behzad Najafian, E. Svarstad, L. Bostad, et al.. (2011). Kidney international. Cited 174 times. https://doi.org/10.1038/ki.2010.484

Renal outcomes of agalsidase beta treatment for Fabry disease: role of proteinuria and timing of treatment initiation

D. Warnock, A. Ortiz, M. Mauer, et al.. (2011). Nephrology Dialysis Transplantation. Cited 167 times. https://doi.org/10.1093/ndt/gfr420

Renal complications of Fabry disease in children

Behzad Najafian, M. Mauer, R. Hopkin, et al.. (2013). Pediatric Nephrology. Cited 47 times. https://doi.org/10.1007/s00467-012-2222-9

Mosaicism of Podocyte Involvement Is Related to Podocyte Injury in Females with Fabry Disease

M. Mauer, E. Glynn, E. Svarstad, et al.. (2014). PLoS ONE. Cited 37 times. https://doi.org/10.1371/journal.pone.0112188

Quantitating Glomerular Endothelial Fenestration: An Unbiased Stereological Approach

Behzad Najafian, M. Mauer. (2011). American Journal of Nephrology. Cited 13 times. https://doi.org/10.1159/000327075
NCPI Dataset Catalog
Feedback & Support
v0.9.0-d9e5747